Market Cap

Enveric Biosciences, Inc. Market Capitalization:

$3.8 Million

USD as of Jan. 1, 2026

business Enveric Biosciences, Inc. Company Profile

Enveric Biosciences, Inc. Main Stock Listing

NASDAQ: ENVB

Market Capitalization History of Enveric Biosciences, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Enveric Biosciences, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $3.8 M 15.32%
Jan. 1, 2025 $3.3 M 10.47%
Jan. 1, 2024 $2.9 M -49.34%
Jan. 1, 2023 $5.8 M 341.82%
Jan. 1, 2022 $1.3 M -82.81%
Jan. 1, 2021 $7.7 M -29.39%
Jan. 1, 2020 $10.9 M -77.22%
Jan. 1, 2019 $47.6 M -90.98%
Jan. 1, 2018 $528.1 M -60.83%
Jan. 1, 2017 $1.35 B 8.14%
Jan. 1, 2016 $1.25 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Enveric Biosciences, Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

Enveric Biosciences, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ENVB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.